Last update Aug. 13, 2024
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Primidone is also known as
Primidone in other languages or writings:
Main tradenames from several countries containing Primidone in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by El Parto Es Nuestro of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Primidone is an antiepileptic used to treat focal, psychomotor, and tonic-clonic type epileptic seizures and essential tremor. It is partially metabolized to phenobarbital. Oral administration in one or two daily doses.
It is excreted in breast milk in moderate amounts, with a relative dose of about 10%, sufficient to cause problems to the infant. (Harden 2009, Moretti 2000, Meyer 1988, Kaneko 1979, Niebyl 1979)
Plasma levels within the therapeutic range have been measured in some infants born to mothers taking primidone. (LactMed, Kuhnz 1988, Nau 1980)
Several cases of sedation, poor feeding and one case of death by suffocation in infants have been described, presumably attributed to primidone taken by their mothers.. (LacMed, Kuhnz 1984)
Newborns of mothers who took primidone during pregnancy and were not breastfed had withdrawal symptoms. (Rauchenzauner 2011, Kuhnz 1988)
A newborn whose mother was taking Primidone and carbamazepine during the first postpartum month did not present any problems. (Niebyl 1979)
Some authors consider this medication prorbablementre compatible with lactation, monitoring the appearance of sedation, apnea and feeding difficulties, especially during the neonatal period and assessing the desirability of measuring plasma levels in the infant. (LactMed, Crettenand 2018, Veiby 2015, Davanzo 2013, O'Connor 2009, Pennell 2006, O'Brien 2005)